Re:Study of Theranos Medical Tests Finds Irregular Results
by kevinskii on Tuesday March 29, 2016 @12:01AM
(#11379400)
“There’s actually pretty widespread variability in these clinical measures, even between the reference labs,” said Eric Schadt, chairman of genetics and genomic sciences at the Icahn School and an author of the report. “But Theranos was more outside of range and outside of range in ways that would impact clinical decision-making.”
"There was as much variability between LabCorp and Quest as there was between Theranos and LabCorp or Theranos and Quest."(1)
Also a link to the actual paper in case anybody feels like reading it from the horse's mouth (2)
(1) http://www.techinsider.io/theranos-study-compares-blood-test...
(2) http://www.jci.org/articles/view/86318